A new analysis of the Jupiter study--designed to show whether AstraZeneca's Crestor was better than placebo at cutting cholesterol--found that fewer Crestor patients got pneumonia during the study compared with those receiving placebo: 214 versus 257, to be exact. Crestor patients were also less likely to develop other sorts of infections, too.
2010/09/15
Killing us softly with their drugs
The BigPharma DrugLords will do ANYTHING to market their statin killer drugs to as many people as they can get their sites on! It is shocking even after so many adverse events occur on these drugs... Now they want to market them for pneumonia! What's next: cancer treatment? arthritis fighters? Oh wait! They are already hailing those illnesses as being treatable with statins!
Killing us softly with their drugs, killing us softly....
Here's a little article with a link to a bigger article in Bloomberg. It shocks me the length at which they will go to recoup the billions they spend on trying to get drugs onto the market.....
Statins show promise for yet another use
September 14, 2010 — 10:30am ET | By Tracy Staton
Statin drugs--those ubiquitous cholesterol-lowering pills--have been hailed as potential treatments for everything from cancer to rheumatoid arthritis. And researchers now say the drugs could be pneumonia-fighters.
This isn't a bolt out of the blue; a 2008 study showed that people hospitalized with pneumonia were less likely to die if they used a statin drug. Other data suggests that statins may help reduce inflammation and prevent a dysfunctional immune system from attacking healthy tissue, Bloomberg reports. The new study has researchers calling for trials of statins in lung disease patients
- read the news from Bloomberg:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment